SFDA-2023-0077-V077

Type IB variation for application SFDA-2023-0077. Type IB variation: Specification Change for Thymosilib — routine update

Variation Number
SFDA-2023-0077-V077
Type
Type IB
Application
SFDA-2023-0077
Change
CHG-2024-0077
Status
Overdue
Fee
€3,845
Submitted
2023-09-18
Approved
—
Description

Type IB variation: Specification Change for Thymosilib — routine update